Caricamento...
Anlotinib: A Novel Targeted Drug for Bone and Soft Tissue Sarcoma
Bone and soft tissue sarcomas account for approximately 15% of pediatric solid malignant tumors and 1% of adult solid malignant tumors. There are over 50 subtypes of sarcomas, each of which is notably heterogeneous and manifested by remarkable phenotypic and morphological variability. Anlotinib is a...
Salvato in:
| Pubblicato in: | Front Oncol |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8173120/ https://ncbi.nlm.nih.gov/pubmed/34094958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.664853 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|